https://www.japanmedai.com/blog/2026-10-15 https://www.japanmedai.com/blog/2026-09-23-alk-lung-cancer-second-opinion.html2026-09-23 https://www.japanmedai.com/blog/2026-09-23-dechuan-in-tokyo-wechat-medical-platform.html2026-09-23 https://www.japanmedai.com/blog/2026-09-23-fus-als-ulefnersen-second-opinion.html2026-09-23 https://www.japanmedai.com/blog/2026-09-24-cancer-conference-new-treatment-second-opinion.html2026-09-24 https://www.japanmedai.com/blog/2026-09-25-recurrent-head-neck-cancer-bnct-second-opinion.html2026-09-25 https://www.japanmedai.com/blog/2026-09-27-biliary-tract-cancer-adjuvant-s1-second-opinion.html2026-09-27 https://www.japanmedai.com/blog/2026-09-28-hcc-fl-gpc3-atezolizumab-bevacizumab-second-opinion.html2026-09-28 https://www.japanmedai.com/blog/2026-09-29-adult-onset-non-5q-sma-lrp12-second-opinion.html2026-09-29 https://www.japanmedai.com/blog/2026-09-29-japanmed-ai-launch-japan-medical-second-opinion-bnct-ips.html2026-09-29 https://www.japanmedai.com/blog/2026-09-30-cancer-genomic-panel-targeted-therapy-second-opinion.html2026-09-30 https://www.japanmedai.com/blog/2026-10-01-rectal-cancer-adhesion-barrier-second-opinion.html2026-10-01 https://www.japanmedai.com/blog/2026-10-04-brain-tumor-mri-progression-second-opinion.html2026-10-04 https://www.japanmedai.com/blog/2026-10-05-prior-70gy-head-neck-cancer-bnct.html2026-10-05 https://www.japanmedai.com/blog/2026-10-08-recurrent-head-neck-cancer-local-treatment-after-radiotherapy.html2026-10-08 https://www.japanmedai.com/blog/2026-10-11-recurrent-head-neck-cancer-japan-second-opinion-candidates.html2026-10-11 https://www.japanmedai.com/blog/2026-10-14-recurrent-head-neck-cancer-prior-radiotherapy-plan-second-opinion.html2026-10-14